Worldwide efforts to find a solution to the current Covid-19 pandemic are starting to produce results.
As reported by the BBC last week, scientists at Oxford University have been working on developing a vaccine for Covid-19 since early January and are hoping to have around a million doses of the vaccine available by September of this year.
At this stage, however, the proposed vaccine needs to undergo human testing to confirm its safety and its efficacy in prompting an immune response to Covid-19. Recruitment of volunteers began in March and testing is now underway. It is hoped that results will be available by August.
Scientists and pharmaceutical companies around the world are trying to develop a vaccine for Covid-19 as quickly as possible. Over the last couple of months, the UK government has given over £200 million to support the work of CEPI (the Coalition for Epidemic Preparedness Innovations) in developing a vaccine against this swift-spreading virus. CEPI is a global organisation co-ordinating and supporting research and vaccine development programmes across the world, including the work at the University of Oxford, as well as research at the University of Hong Kong and the University of Queensland, Australia.
Producing an effective vaccine is seen as the way forward in combatting the spread of the new coronavirus, Covid-19.
Speak to a solicitor
If you or a loved one are struggling with the long-term, debilitating impact of medical negligence, contact Glynns to talk to a specialist solicitor.
Please call us on 0800 234 3300 (or from a mobile 01275 334030) or complete our Online Enquiry Form.
Share Article With:
|
|
|
|
|
|
